Analyst Ratings for Fate Therapeutics (FATE) [Neutrals]

FATE Rating Summary

FATE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on FATE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $115.08 (+69.7%) * Over Last 12-Mos
Rating Score: 7.5 / 10   Percentile Rank: 77%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/26/2021 Morgan Stanley Michael Ulz New Coverage Equalweight
(N/A)
77.00
(N/A)
71.53
(67.82)
-5.19% Details
2/11/2021 Citi Yigal Nochomovitz Downgrade Neutral
(Buy)
N/A
(N/A)
103.31
(67.82)
-34.35% Details
Like FATE Ratings? Also take a look at BEAM, TSLA, SPLK, RPTX

FATE Ratings News